Regulation of H3K9me3 during preimplantation development†
Regulation of H3K9me3 during preimplantation development†
复制标题
DOI:
10.1093/biolre/ioy201
复制
发表时间:
2018-09
影响因子:
3.6
通讯作者:
F. Aoki
中科院分区:
文献类型:
--
作者:
F. Aoki
After fertilization, zygotes acquire totipotency, the ability to differentiate into any type of cell. Embryos lose this ability during preimplantation development. Over the course of these processes, gene expression patterns and chromatin structures change dynamically [1, 2]. Concomitantly with these changes, epigenetic modifications drastically shift, a change that is at least partially responsible for changes in gene expression and chromatin structure and the loss of totipotency [3]. One of these epigenetic modifications, H3K9me3, has been shown to play important roles in heterochromatin formation and repression of gene expression in various types of cells, including preimplantation embryos [4, 5]. Furthermore, it has been reported that decreasing the level of H3K9me3 improves the efficiency of reprogramming in somatic cell nuclei transferred to enucleated oocytes, suggesting that H3K9me3 is one of the determinants of embryo plasticity [6]. Although the functions of H3K9me3 in preimplantation embryos have been thoroughly investigated, the mechanisms by which this epigenetic modification is regulated are not well understood.A recent paper published in EMBO Journal, by Heng-Yu Fan’s laboratory [7] reported that DCAF13, an adaptor of CRL4 ubiquitin E3 ligase, is involved in the regulation of H3K9me3 in preimplantation embryos. The authors showed that DCAF13 expression increases at the 8-cell to morula stage. Furthermore, Dcaf13 knockout (KO) caused an increase in SUV39H1 and H3K9me3 levels and developmental arrest of embryos before the morula stage. The authors thus suggested that DCAF13 regulates H3K9me3 by degrading SUV39H1 via the ubiquitin pathway and plays an important role in preimplantation development.